Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Cancer Research and Clinical Oncology|April 14, 2017
MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus invivoGiuseppina Improta, Cathrin Ritter, Angela Pettinato, et al.
Anticancer Research|June 29, 2026
CTNNB1 Mutations in Non-small Cell Lung Cancer: Clinicopathological Characteristics of a Small CohortGiuseppina Improta, Giulia Vita, Alfredo Tartarone, et al.
Oncoimmunology|November 2, 2013
Biological insights into BRAF<sup>V600</sup> mutations in melanoma patient: Not mere therapeutic targetsGiuseppina Improta, Giuseppe Pelosi, Elena Tamborini, et al.
Journal of Clinical Pathology|May 8, 2016
Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patientsGian Franco Zannoni, Giuseppina Improta, Angela Pettinato, et al.
Anticancer Research|April 22, 2011
Polymorphisms of the CYP1A1, CYP2E1 and XRCC1 genes and cancer risk in a Southern Italian population: a case-control studyGabriella Bianchino, Achille Cittadini, Vitina Grieco, et al.
Anticancer Research|February 11, 2014
PSA nadir and outcome in 100 patients with pT3b prostate cancerPietro Pepe, Giuseppina Improta, Filippo Fraggetta, et al.
Virchows Archiv : an International Journal of Pathology|June 4, 2014
Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinomaGian Franco Zannoni, Giuseppina Improta, Gaia Chiarello, et al.
Anticancer Research|November 27, 2008
Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian populationGiuseppina Improta, Alessandro Sgambato, Gabriella Bianchino, et al.
Pageof 4